VDR and cancer: Therefore, topical and/or systemically applicated vitamin d (or in combination with vitamin A derivates (21) may be considered as a possible new, nontoxic, adjuvant cancer therapy, which can be easily introduced into the classic protocols of clinical cancer therapy without any supplementary risk for VDR+ patients.